Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis

Journal of Infectious Diseases

Volumn 174, Issue 6, 1996, Pages 1345-1347

  Campos, José ^a   Román, Federico ^b   Georgiou, Marios ^b   Garcia, Concepción ^b   Gómez Lus, Rafael ^b   Cantón, Rafael ^b   Escobar, Hector ^b   Baquero, Fernando ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; CASE REPORT; CYSTIC FIBROSIS; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 0029852625     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.6.1345     Document Type: Article

References (14)

1. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51.
2. Chin NX, Neu HC. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1984;25:319-26.
3. Stutman HR. Summary of a workshop on ciprofloxacin use in patients with cystic fibrosis. Pediatr Infect Dis J 1987;6:932-5.
4. Scully BE, Nakatomi M, Ores C, Davidson S, Neu HC. Ciprofloxacin therapy in cystic fibrosis. Am J Med 1987;82(suppl 4A):196-201.
5. Barriere SL, Hindier JA. Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease. Ann Pharmacother 1993;27:309-10.
6. Gould IM, Forbes KJ, Gordon GS. Quinolone resistant Haemophilus influenzae. J Antimicrob Chemother 1994;133:187-8.
7. Corkill JE, Percival A, McDonald P, Bamber AI. Detection of quinolone resistance in Haemophilus spp. J Antimicrob Chemother 1994;34:841-4.
8. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3d ed. Approved standard. Villanova, PA: NCCLS, 1993:13(25); document M7-A3.
9. Campos J, Chanyangam M, deGroot R, Smith AL, Tenover FC, Reig R. Genetic relatedness of antibiotic resistance determinants in multiply resistant Haemophilus influenzae. J Infect Dis 1989;160:810-7.
10. Murphy TF, Dudas KC, Mylotte JM, Apicella MA. A subtyping system for nontypable Haemophilus influenzae based on outer-membrane proteins. J Infect Dis 1983;147:838-46.
11. Lee JJ, Smith HO. Sizing of the Haemophilus influenzae Rd genome by pulsed-field agarose gel electrophoresis. J Bacteriol 1988;170:4402-5.
12. Bryskier A. Fluoroquinolones: mechanisms of action and resistance. Int J Antimicrob Agents 1993;2:151-84.
13. Georgiou M, Muñoz R, Román F, et al. Ciprofloxacin resistant Haemophilus influenzae possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother 1996;40:1741-4.
14. Goldfarb J, Stern RC, Reed MD, Yamashita TS, Myers CM, Blumer JL. Ciprofloxacin monotherapy for acute pulmonary' exacerbations of cystic fibrosis. Am J Med 1987;82(suppl 4A):174-9.